Loading clinical trials...
Loading clinical trials...
Epidemiologic Review and Prospective Observation of COPD and Health in Korea
This study is designed as a multicenter, prospective and retrospective and descriptive epidemiology study. This study is planned to evaluate 2 years of exacerbation in COPD patients and to investigate correlation of COPD disease progress and its exacerbation. This study is designed with 6 months of subject enrollments, 12 months of retrospective study, and 12 months of prospective study. Hence, each patient will be participating in the study for 12 months, while the actual data collections from the patients will take a total of 24 months. The statistical analysis of this study will be done twice, at the completion of 1 year retrospective data collection and at the completion of next 1 year follow-up. The 1st statistical analysis of retrospective study includes exacerbation rate, duration of hospitalization for exacerbation and lung function test for the past 1 year from the enrollment and comorbidities, COPD assessment (CAT) and COPD medication at the enrollment will be analyzed. The 2nd statistical analysis of prospective 1-year follow-up includes changes in exacerbation rates, comparison of lung function test results, comorbidities, COPD assessments (CAT) and COPD medications of retrospective and prospective studies for the 2 years as well as mortality rate.
Age
40 - No limit years
Sex
ALL
Healthy Volunteers
No
Nycomed Investigational Site
Busan, South Korea
Nycomed Investigational Site
Chungcheongnam-do, South Korea
Nycomed Investigational Site
Daegu, South Korea
Nycomed Investigational Site
Daejeon, South Korea
Nycomed Investigational Site
Gangwon-do, South Korea
Nycomed Investigational Site
Gwangju, South Korea
Nycomed Investigational Site
Gyeongbuk, South Korea
Nycomed Investigational Site
Gyeonggi-do, South Korea
Nycomed Investigational Site
Gyeongsangnam-do, South Korea
Nycomed Investigational Site
Incheon, South Korea
Start Date
July 1, 2011
Primary Completion Date
January 1, 2013
Completion Date
January 1, 2013
Last Updated
April 18, 2013
1,118
ACTUAL participants
Lead Sponsor
Takeda
NCT07477600
NCT07462221
NCT07351929
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions